India on 12 September 2017 got its first virology laboratory to develop homoeopathy drugs against diseases such as H1N1 (swine flu), dengue, chikungunya etc. Union minister of state for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Shripad Yesso Naik, inaugurated the state-of-the art laboratory at Kolkata’s Dr Anjali Chatterjee Regional Research Institute for Homeopathy (RRIH).
The laboratory is recognized by the Calcutta University to undertake research work of the PhD students in the field of homeopathy. The laboratory, established at a cost of ₹ 8 crore, is the only one in India for conducting basic and fundamental research in homeopathy for viral diseases such as influenza, Japanese encephalitis, dengue, chikunguniya and swine flu. The laboratory will also be used to create new drugs and technologies in treating these viral diseases.
West Bengal’s National Institute of Homoeopathy (NIH) and RRIH are expected to actively collaborate to impart practical training to the students and research scholars in virus research, both in laboratory and in the field. This institute has undertaken several clinical research studies such as autism, psoriasis, vitiligo, breast cancer, hypertension, migraine etc. along with proving of new drugs in homoeopathy with their clinical validations.